

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.58735173 |
| 2 | negative regulation of cell killing (GO:0031342) | 5.58735173 |
| 3 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.54225066 |
| 4 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.42489377 |
| 5 | viral transcription (GO:0019083) | 5.05180255 |
| 6 | neutrophil activation involved in immune response (GO:0002283) | 5.04406876 |
| 7 | ribosomal small subunit assembly (GO:0000028) | 4.99914340 |
| 8 | translational termination (GO:0006415) | 4.83718513 |
| 9 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.72709426 |
| 10 | DNA strand elongation involved in DNA replication (GO:0006271) | 4.68783319 |
| 11 | DNA unwinding involved in DNA replication (GO:0006268) | 4.59336642 |
| 12 | telomere maintenance via semi-conservative replication (GO:0032201) | 4.53212251 |
| 13 | DNA strand elongation (GO:0022616) | 4.46007576 |
| 14 | negative thymic T cell selection (GO:0045060) | 4.43271175 |
| 15 | negative T cell selection (GO:0043383) | 4.40743120 |
| 16 | translational elongation (GO:0006414) | 4.33052152 |
| 17 | positive thymic T cell selection (GO:0045059) | 4.30630165 |
| 18 | DNA replication initiation (GO:0006270) | 4.25590515 |
| 19 | maturation of SSU-rRNA (GO:0030490) | 4.22114941 |
| 20 | positive regulation by symbiont of host defense response (GO:0052509) | 4.20017781 |
| 21 | modulation by symbiont of host defense response (GO:0052031) | 4.20017781 |
| 22 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.20017781 |
| 23 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.20017781 |
| 24 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.20017781 |
| 25 | modulation by symbiont of host immune response (GO:0052553) | 4.20017781 |
| 26 | positive regulation of granulocyte differentiation (GO:0030854) | 4.15120393 |
| 27 | ribosomal small subunit biogenesis (GO:0042274) | 4.11218395 |
| 28 | detection of bacterium (GO:0016045) | 4.08964165 |
| 29 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 4.04988390 |
| 30 | detection of other organism (GO:0098543) | 4.04292834 |
| 31 | DNA deamination (GO:0045006) | 3.94557426 |
| 32 | cotranslational protein targeting to membrane (GO:0006613) | 3.93640002 |
| 33 | protein targeting to ER (GO:0045047) | 3.93315163 |
| 34 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 3.92328092 |
| 35 | response to interleukin-15 (GO:0070672) | 3.88795062 |
| 36 | translational initiation (GO:0006413) | 3.87884079 |
| 37 | B cell receptor signaling pathway (GO:0050853) | 3.84552727 |
| 38 | thymic T cell selection (GO:0045061) | 3.83051407 |
| 39 | telomere maintenance via recombination (GO:0000722) | 3.80762572 |
| 40 | viral life cycle (GO:0019058) | 3.78920305 |
| 41 | T cell selection (GO:0045058) | 3.77895224 |
| 42 | positive T cell selection (GO:0043368) | 3.77684633 |
| 43 | immunoglobulin mediated immune response (GO:0016064) | 3.74169677 |
| 44 | response to peptidoglycan (GO:0032494) | 3.73250854 |
| 45 | cellular protein complex disassembly (GO:0043624) | 3.72847195 |
| 46 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.71176853 |
| 47 | protein localization to endoplasmic reticulum (GO:0070972) | 3.65590874 |
| 48 | neutrophil activation (GO:0042119) | 3.64007163 |
| 49 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.60718080 |
| 50 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.58534439 |
| 51 | mitotic recombination (GO:0006312) | 3.57506412 |
| 52 | regulation of mast cell degranulation (GO:0043304) | 3.56548073 |
| 53 | regulation of B cell differentiation (GO:0045577) | 3.53502973 |
| 54 | cellular response to interleukin-15 (GO:0071350) | 3.51572058 |
| 55 | T cell migration (GO:0072678) | 3.49700069 |
| 56 | protein complex disassembly (GO:0043241) | 3.48521101 |
| 57 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.47778038 |
| 58 | tolerance induction (GO:0002507) | 3.46757054 |
| 59 | DNA replication checkpoint (GO:0000076) | 3.45420736 |
| 60 | protein localization to kinetochore (GO:0034501) | 3.41144595 |
| 61 | leukocyte degranulation (GO:0043299) | 3.40038056 |
| 62 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 3.36837746 |
| 63 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.36627595 |
| 64 | granulocyte activation (GO:0036230) | 3.33879738 |
| 65 | formation of translation preinitiation complex (GO:0001731) | 3.32773579 |
| 66 | myeloid cell activation involved in immune response (GO:0002275) | 3.30382548 |
| 67 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 3.29794171 |
| 68 | telomere maintenance via telomere lengthening (GO:0010833) | 3.29316893 |
| 69 | negative regulation of T cell mediated immunity (GO:0002710) | 3.28450422 |
| 70 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.26351584 |
| 71 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.25744881 |
| 72 | mucosal-associated lymphoid tissue development (GO:0048537) | 3.24105766 |
| 73 | Peyers patch development (GO:0048541) | 3.24105766 |
| 74 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.22585202 |
| 75 | respiratory burst (GO:0045730) | 3.21703654 |
| 76 | macrophage activation involved in immune response (GO:0002281) | 3.21504240 |
| 77 | macromolecular complex disassembly (GO:0032984) | 3.20905491 |
| 78 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.19736493 |
| 79 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.18724886 |
| 80 | response to muramyl dipeptide (GO:0032495) | 3.16997848 |
| 81 | N-acetylneuraminate metabolic process (GO:0006054) | 3.16366757 |
| 82 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.14902904 |
| 83 | regulation of protein heterodimerization activity (GO:0043497) | 3.13807636 |
| 84 | protein localization to chromosome, centromeric region (GO:0071459) | 3.13758971 |
| 85 | regulation of leukocyte degranulation (GO:0043300) | 3.13178502 |
| 86 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.12686841 |
| 87 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.12686841 |
| 88 | ribosomal large subunit biogenesis (GO:0042273) | 3.11921391 |
| 89 | regulation of granulocyte differentiation (GO:0030852) | 3.11804205 |
| 90 | B cell mediated immunity (GO:0019724) | 3.11459284 |
| 91 | regulation of T cell tolerance induction (GO:0002664) | 3.11130902 |
| 92 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.10813734 |
| 93 | response to host immune response (GO:0052572) | 3.10813734 |
| 94 | negative regulation of interleukin-12 production (GO:0032695) | 3.08076983 |
| 95 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.07788925 |
| 96 | detection of external biotic stimulus (GO:0098581) | 3.07114039 |
| 97 | megakaryocyte development (GO:0035855) | 3.06520429 |
| 98 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.06216904 |
| 99 | type I interferon signaling pathway (GO:0060337) | 3.03879886 |
| 100 | cellular response to type I interferon (GO:0071357) | 3.03879886 |
| 101 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.03770667 |
| 102 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 3.02711611 |
| 103 | mast cell activation (GO:0045576) | 3.02167724 |
| 104 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.02162139 |
| 105 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 3.02003300 |
| 106 | response to type I interferon (GO:0034340) | 3.01726536 |
| 107 | positive regulation of mast cell activation (GO:0033005) | 2.96965353 |
| 108 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.96037546 |
| 109 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.95709696 |
| 110 | regulation of tolerance induction (GO:0002643) | 2.93791769 |
| 111 | negative regulation of RNA splicing (GO:0033119) | 2.93649117 |
| 112 | negative regulation of phagocytosis (GO:0050765) | 2.91887237 |
| 113 | response to host (GO:0075136) | 2.91834592 |
| 114 | response to host defenses (GO:0052200) | 2.91834592 |
| 115 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.91834592 |
| 116 | V(D)J recombination (GO:0033151) | 2.90003172 |
| 117 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 2.89016202 |
| 118 | mRNA catabolic process (GO:0006402) | 2.86378391 |
| 119 | regulation of mast cell activation (GO:0033003) | 2.85615990 |
| 120 | RNA catabolic process (GO:0006401) | 2.83889106 |
| 121 | regulation of regulatory T cell differentiation (GO:0045589) | 2.79505998 |
| 122 | amino sugar catabolic process (GO:0046348) | 2.79015543 |
| 123 | DNA replication-dependent nucleosome organization (GO:0034723) | 2.78391972 |
| 124 | DNA replication-dependent nucleosome assembly (GO:0006335) | 2.78391972 |
| 125 | translation (GO:0006412) | 2.77885712 |
| 126 | defense response to protozoan (GO:0042832) | 2.76708099 |
| 127 | leukocyte aggregation (GO:0070486) | 2.76673577 |
| 128 | germinal center formation (GO:0002467) | 2.76529809 |
| 129 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.76366825 |
| 130 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.76366825 |
| 131 | regulation of platelet aggregation (GO:0090330) | 2.76185160 |
| 132 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.75601106 |
| 133 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.75543407 |
| 134 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.75351295 |
| 135 | negative regulation of innate immune response (GO:0045824) | 2.73364463 |
| 136 | positive regulation of isotype switching (GO:0045830) | 2.73048120 |
| 137 | establishment of integrated proviral latency (GO:0075713) | 2.72824341 |
| 138 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.71424674 |
| 139 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.70661097 |
| 140 | lymphocyte homeostasis (GO:0002260) | 2.69564172 |
| 141 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.68920796 |
| 142 | T cell receptor signaling pathway (GO:0050852) | 2.68724867 |
| 143 | DNA ligation (GO:0006266) | 2.65603832 |
| 144 | mitotic nuclear envelope disassembly (GO:0007077) | 2.64538599 |
| 145 | ribonucleoprotein complex biogenesis (GO:0022613) | 2.62117975 |
| 146 | mitotic sister chromatid segregation (GO:0000070) | 2.60821554 |
| 147 | sequestering of actin monomers (GO:0042989) | 2.58920123 |
| 148 | IMP biosynthetic process (GO:0006188) | 2.58768407 |
| 149 | GMP metabolic process (GO:0046037) | 2.58752673 |
| 150 | erythrocyte maturation (GO:0043249) | 2.58645686 |
| 151 | protein targeting to membrane (GO:0006612) | 2.57088342 |
| 152 | peptidyl-arginine omega-N-methylation (GO:0035247) | 2.57065327 |
| 153 | DNA duplex unwinding (GO:0032508) | 2.54417273 |
| 154 | DNA geometric change (GO:0032392) | 2.53427515 |
| 155 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.52844405 |
| 156 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.52844405 |
| 157 | negative regulation of mRNA processing (GO:0050686) | 2.52684931 |
| 158 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.52676329 |
| 159 | morphogenesis of an endothelium (GO:0003159) | 2.52251787 |
| 160 | endothelial tube morphogenesis (GO:0061154) | 2.52251787 |
| 161 | heterochromatin organization (GO:0070828) | 2.52130493 |
| 162 | T cell apoptotic process (GO:0070231) | 2.50884472 |
| 163 | DNA damage response, detection of DNA damage (GO:0042769) | 2.50402528 |
| 164 | positive regulation of B cell differentiation (GO:0045579) | 2.49971070 |
| 165 | T cell homeostasis (GO:0043029) | 2.49891220 |
| 166 | translesion synthesis (GO:0019985) | 2.48328900 |
| 167 | rRNA processing (GO:0006364) | 2.46840236 |
| 168 | base-excision repair (GO:0006284) | 2.46031676 |
| 169 | regulation of histone H3-K9 methylation (GO:0051570) | 2.45592168 |
| 170 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 2.44646487 |
| 171 | telomere organization (GO:0032200) | 2.44254185 |
| 172 | telomere maintenance (GO:0000723) | 2.42876435 |
| 173 | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377) | 2.40308809 |
| 174 | mRNA splicing, via spliceosome (GO:0000398) | 2.40308809 |
| 175 | transcription-coupled nucleotide-excision repair (GO:0006283) | 2.40067883 |
| 176 | spliceosomal snRNP assembly (GO:0000387) | 2.39979850 |
| 177 | somatic cell DNA recombination (GO:0016444) | 2.39886289 |
| 178 | somatic diversification of immune receptors via germline recombination within a single locus (GO:000 | 2.39886289 |
| 179 | RNA splicing, via transesterification reactions (GO:0000375) | 2.39294426 |
| 180 | rRNA metabolic process (GO:0016072) | 2.38366835 |
| 181 | cellular extravasation (GO:0045123) | 2.37961269 |
| 182 | sister chromatid segregation (GO:0000819) | 2.37724768 |
| 183 | membrane disassembly (GO:0030397) | 2.37714414 |
| 184 | nuclear envelope disassembly (GO:0051081) | 2.37714414 |
| 185 | regulation of gamma-delta T cell activation (GO:0046643) | 2.35183224 |
| 186 | CENP-A containing nucleosome assembly (GO:0034080) | 2.33760892 |
| 187 | regulation of double-strand break repair via homologous recombination (GO:0010569) | 2.33241014 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 7.83122463 |
| 2 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.94223590 |
| 3 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.64649725 |
| 4 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.14407559 |
| 5 | MYC_22102868_ChIP-Seq_BL_Human | 3.02967272 |
| 6 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.95133212 |
| 7 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.76193688 |
| 8 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.64419392 |
| 9 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.59970075 |
| 10 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.55993804 |
| 11 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.38062474 |
| 12 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.35124244 |
| 13 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.28410887 |
| 14 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.23899684 |
| 15 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.20881326 |
| 16 | * RUNX_20019798_ChIP-Seq_JUKART_Human | 2.20622033 |
| 17 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.20301991 |
| 18 | SPI1_23127762_ChIP-Seq_K562_Human | 2.19350786 |
| 19 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.19336557 |
| 20 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.11084067 |
| 21 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.02094033 |
| 22 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.01743620 |
| 23 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.00104734 |
| 24 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.99262811 |
| 25 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.97993894 |
| 26 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.95984148 |
| 27 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.95151812 |
| 28 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.94961265 |
| 29 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.90239751 |
| 30 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.88751016 |
| 31 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.83292573 |
| 32 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.82220905 |
| 33 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.81953474 |
| 34 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.81896711 |
| 35 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.81127566 |
| 36 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.77807595 |
| 37 | * SCL_19346495_ChIP-Seq_HPC-7_Human | 1.76399498 |
| 38 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.75489313 |
| 39 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.73006605 |
| 40 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.70830796 |
| 41 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.70807686 |
| 42 | MAF_26560356_Chip-Seq_TH1_Human | 1.69929472 |
| 43 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.69185806 |
| 44 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.68348105 |
| 45 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.67941699 |
| 46 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.65903112 |
| 47 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.65840986 |
| 48 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.64020706 |
| 49 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.63839397 |
| 50 | * GATA1_19941826_ChIP-Seq_K562_Human | 1.62348384 |
| 51 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.61598866 |
| 52 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.60858107 |
| 53 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.59932362 |
| 54 | * TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.54741565 |
| 55 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.53091397 |
| 56 | * LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.50590895 |
| 57 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.49123184 |
| 58 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.48450499 |
| 59 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.48002956 |
| 60 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.46858356 |
| 61 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.46580070 |
| 62 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.45184847 |
| 63 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.45075968 |
| 64 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.43124977 |
| 65 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.41945654 |
| 66 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.40974716 |
| 67 | * MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.40670585 |
| 68 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.40131813 |
| 69 | * MYB_26560356_Chip-Seq_TH2_Human | 1.39680887 |
| 70 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.37913865 |
| 71 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.37654843 |
| 72 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.37522257 |
| 73 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.36934899 |
| 74 | GATA1_22025678_ChIP-Seq_K562_Human | 1.36911287 |
| 75 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.36300517 |
| 76 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.34825832 |
| 77 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.33046699 |
| 78 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.33002531 |
| 79 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.31922885 |
| 80 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.31775370 |
| 81 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.31768741 |
| 82 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.31265823 |
| 83 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.30755817 |
| 84 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.29645213 |
| 85 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.29090601 |
| 86 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.28724704 |
| 87 | * MYB_26560356_Chip-Seq_TH1_Human | 1.28425025 |
| 88 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.27729387 |
| 89 | * NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.27661337 |
| 90 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.27380066 |
| 91 | MAF_26560356_Chip-Seq_TH2_Human | 1.27099749 |
| 92 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.25628079 |
| 93 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.25173931 |
| 94 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.23643151 |
| 95 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.23493676 |
| 96 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.23127859 |
| 97 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.21950715 |
| 98 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.21576760 |
| 99 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.21422059 |
| 100 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.20681848 |
| 101 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.20665913 |
| 102 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.20103242 |
| 103 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.19851400 |
| 104 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.19412458 |
| 105 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.18361941 |
| 106 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.17891074 |
| 107 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.16244158 |
| 108 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.15733764 |
| 109 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.15264064 |
| 110 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.12013856 |
| 111 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.11866039 |
| 112 | P68_20966046_ChIP-Seq_HELA_Human | 1.11859776 |
| 113 | * GATA2_19941826_ChIP-Seq_K562_Human | 1.11217819 |
| 114 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.10389240 |
| 115 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.10163149 |
| 116 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.09403786 |
| 117 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.09356466 |
| 118 | * DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.08783420 |
| 119 | * SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.08010447 |
| 120 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.07831831 |
| 121 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.07776206 |
| 122 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.06929826 |
| 123 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.06773664 |
| 124 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.06753205 |
| 125 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.06301540 |
| 126 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.06123442 |
| 127 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.05475698 |
| 128 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.05394677 |
| 129 | * GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.05310315 |
| 130 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.03937552 |
| 131 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.03531472 |
| 132 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.02570351 |
| 133 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.01788858 |
| 134 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.01695698 |
| 135 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.01541301 |
| 136 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.01389671 |
| 137 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.00690743 |
| 138 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.00322501 |
| 139 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 0.99327524 |
| 140 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.99141841 |
| 141 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.98273444 |
| 142 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.97870188 |
| 143 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 0.96957538 |
| 144 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.96890055 |
| 145 | * KDM2B_26808549_Chip-Seq_DND41_Human | 0.94751622 |
| 146 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.94731587 |
| 147 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.94663350 |
| 148 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.94519887 |
| 149 | * GATA3_26560356_Chip-Seq_TH2_Human | 0.93817224 |
| 150 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.93470065 |
| 151 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.92619483 |
| 152 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.92616750 |
| 153 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.92019997 |
| 154 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.89997859 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003693_abnormal_embryo_hatching | 3.64047007 |
| 2 | MP0010094_abnormal_chromosome_stability | 3.03460674 |
| 3 | MP0003111_abnormal_nucleus_morphology | 2.93491255 |
| 4 | MP0002396_abnormal_hematopoietic_system | 2.85944019 |
| 5 | MP0004957_abnormal_blastocyst_morpholog | 2.75155487 |
| 6 | MP0003763_abnormal_thymus_physiology | 2.68282587 |
| 7 | MP0003077_abnormal_cell_cycle | 2.61115133 |
| 8 | MP0000685_abnormal_immune_system | 2.38442004 |
| 9 | MP0005397_hematopoietic_system_phenotyp | 2.32940902 |
| 10 | MP0001545_abnormal_hematopoietic_system | 2.32940902 |
| 11 | MP0009278_abnormal_bone_marrow | 2.32355181 |
| 12 | MP0000490_abnormal_crypts_of | 2.32128008 |
| 13 | MP0004808_abnormal_hematopoietic_stem | 2.24911368 |
| 14 | MP0009333_abnormal_splenocyte_physiolog | 2.19675253 |
| 15 | * MP0002398_abnormal_bone_marrow | 2.17793039 |
| 16 | MP0003191_abnormal_cellular_cholesterol | 2.01463567 |
| 17 | * MP0002722_abnormal_immune_system | 1.96548398 |
| 18 | MP0000689_abnormal_spleen_morphology | 1.95655076 |
| 19 | MP0008007_abnormal_cellular_replicative | 1.94702318 |
| 20 | MP0001800_abnormal_humoral_immune | 1.93186028 |
| 21 | MP0008057_abnormal_DNA_replication | 1.92630239 |
| 22 | MP0005671_abnormal_response_to | 1.89727783 |
| 23 | * MP0000703_abnormal_thymus_morphology | 1.87829000 |
| 24 | MP0006082_CNS_inflammation | 1.86889076 |
| 25 | MP0003436_decreased_susceptibility_to | 1.81935059 |
| 26 | MP0003656_abnormal_erythrocyte_physiolo | 1.81593642 |
| 27 | MP0002132_abnormal_respiratory_system | 1.73364645 |
| 28 | MP0009785_altered_susceptibility_to | 1.72588027 |
| 29 | MP0008058_abnormal_DNA_repair | 1.72473014 |
| 30 | MP0005451_abnormal_body_composition | 1.70024838 |
| 31 | MP0003172_abnormal_lysosome_physiology | 1.68139979 |
| 32 | * MP0002420_abnormal_adaptive_immunity | 1.66090811 |
| 33 | * MP0002429_abnormal_blood_cell | 1.65309877 |
| 34 | * MP0000716_abnormal_immune_system | 1.64920266 |
| 35 | * MP0001819_abnormal_immune_cell | 1.63784195 |
| 36 | MP0005058_abnormal_lysosome_morphology | 1.60364483 |
| 37 | MP0000465_gastrointestinal_hemorrhage | 1.60351386 |
| 38 | MP0002452_abnormal_antigen_presenting | 1.60012716 |
| 39 | MP0001835_abnormal_antigen_presentation | 1.58004411 |
| 40 | * MP0002019_abnormal_tumor_incidence | 1.55922889 |
| 41 | MP0002405_respiratory_system_inflammati | 1.53076486 |
| 42 | MP0003303_peritoneal_inflammation | 1.52061591 |
| 43 | MP0010352_gastrointestinal_tract_polyps | 1.48807306 |
| 44 | MP0002723_abnormal_immune_serum | 1.48340395 |
| 45 | MP0005025_abnormal_response_to | 1.47396042 |
| 46 | MP0006054_spinal_hemorrhage | 1.46884792 |
| 47 | MP0000350_abnormal_cell_proliferation | 1.44097490 |
| 48 | MP0005464_abnormal_platelet_physiology | 1.40702490 |
| 49 | MP0001851_eye_inflammation | 1.40623179 |
| 50 | MP0008932_abnormal_embryonic_tissue | 1.38949984 |
| 51 | MP0000858_altered_metastatic_potential | 1.38789637 |
| 52 | MP0005000_abnormal_immune_tolerance | 1.37611100 |
| 53 | MP0001730_embryonic_growth_arrest | 1.34616844 |
| 54 | MP0003786_premature_aging | 1.33141579 |
| 55 | MP0010155_abnormal_intestine_physiology | 1.32155771 |
| 56 | MP0010307_abnormal_tumor_latency | 1.31204435 |
| 57 | MP0005387_immune_system_phenotype | 1.26062586 |
| 58 | MP0001790_abnormal_immune_system | 1.26062586 |
| 59 | MP0008469_abnormal_protein_level | 1.24887401 |
| 60 | MP0005310_abnormal_salivary_gland | 1.21064056 |
| 61 | MP0005409_darkened_coat_color | 1.19844648 |
| 62 | MP0000313_abnormal_cell_death | 1.19579097 |
| 63 | MP0002166_altered_tumor_susceptibility | 1.19574089 |
| 64 | MP0004510_myositis | 1.18885686 |
| 65 | MP0003724_increased_susceptibility_to | 1.17360962 |
| 66 | MP0002080_prenatal_lethality | 1.11048850 |
| 67 | MP0005075_abnormal_melanosome_morpholog | 1.09747349 |
| 68 | MP0003567_abnormal_fetal_cardiomyocyte | 1.08037831 |
| 69 | MP0009764_decreased_sensitivity_to | 1.07864566 |
| 70 | MP0001853_heart_inflammation | 1.06950785 |
| 71 | MP0002998_abnormal_bone_remodeling | 1.04916464 |
| 72 | MP0002419_abnormal_innate_immunity | 1.04225823 |
| 73 | MP0001697_abnormal_embryo_size | 1.03995730 |
| 74 | MP0008004_abnormal_stomach_pH | 1.03038838 |
| 75 | MP0005023_abnormal_wound_healing | 1.01794915 |
| 76 | MP0005174_abnormal_tail_pigmentation | 1.01488669 |
| 77 | MP0005083_abnormal_biliary_tract | 1.01011722 |
| 78 | MP0003075_altered_response_to | 1.00588895 |
| 79 | MP0002933_joint_inflammation | 1.00185089 |
| 80 | MP0003866_abnormal_defecation | 0.98021564 |
| 81 | MP0001672_abnormal_embryogenesis/_devel | 0.96125234 |
| 82 | MP0005380_embryogenesis_phenotype | 0.96125234 |
| 83 | MP0003566_abnormal_cell_adhesion | 0.95378660 |
| 84 | MP0004381_abnormal_hair_follicle | 0.94261235 |
| 85 | MP0003984_embryonic_growth_retardation | 0.93884043 |
| 86 | MP0000343_altered_response_to | 0.93565151 |
| 87 | MP0009379_abnormal_foot_pigmentation | 0.93305794 |
| 88 | MP0009763_increased_sensitivity_to | 0.92929873 |
| 89 | MP0002086_abnormal_extraembryonic_tissu | 0.91736151 |
| 90 | MP0002088_abnormal_embryonic_growth/wei | 0.91187738 |
| 91 | MP0003123_paternal_imprinting | 0.90328089 |
| 92 | MP0003136_yellow_coat_color | 0.88678867 |
| 93 | MP0003828_pulmonary_edema | 0.88601464 |
| 94 | MP0000477_abnormal_intestine_morphology | 0.88374644 |
| 95 | MP0001845_abnormal_inflammatory_respons | 0.88362759 |
| 96 | MP0001873_stomach_inflammation | 0.87900534 |
| 97 | MP0004147_increased_porphyrin_level | 0.87142819 |
| 98 | MP0001915_intracranial_hemorrhage | 0.86725402 |
| 99 | MP0002085_abnormal_embryonic_tissue | 0.86393122 |
| 100 | MP0002095_abnormal_skin_pigmentation | 0.86392152 |
| 101 | MP0004197_abnormal_fetal_growth/weight/ | 0.85527854 |
| 102 | MP0005166_decreased_susceptibility_to | 0.85398585 |
| 103 | MP0004883_abnormal_blood_vessel | 0.84309718 |
| 104 | MP0000015_abnormal_ear_pigmentation | 0.83618963 |
| 105 | MP0004947_skin_inflammation | 0.83456626 |
| 106 | MP0002877_abnormal_melanocyte_morpholog | 0.83371491 |
| 107 | MP0002006_tumorigenesis | 0.81946386 |
| 108 | MP0001663_abnormal_digestive_system | 0.80706073 |
| 109 | MP0002009_preneoplasia | 0.80213677 |
| 110 | MP0003300_gastrointestinal_ulcer | 0.79220992 |
| 111 | MP0002148_abnormal_hypersensitivity_rea | 0.77628729 |
| 112 | MP0009840_abnormal_foam_cell | 0.75751662 |
| 113 | MP0002160_abnormal_reproductive_system | 0.72677796 |
| 114 | MP0005390_skeleton_phenotype | 0.71566811 |
| 115 | MP0001533_abnormal_skeleton_physiology | 0.71047514 |
| 116 | MP0003448_altered_tumor_morphology | 0.70656182 |
| 117 | MP0003795_abnormal_bone_structure | 0.70122612 |
| 118 | MP0009765_abnormal_xenobiotic_induced | 0.69929578 |
| 119 | MP0009931_abnormal_skin_appearance | 0.68705762 |
| 120 | MP0000249_abnormal_blood_vessel | 0.67629655 |
| 121 | MP0003183_abnormal_peptide_metabolism | 0.67081623 |
| 122 | MP0008874_decreased_physiological_sensi | 0.66956068 |
| 123 | MP0003315_abnormal_perineum_morphology | 0.66567395 |
| 124 | MP0008260_abnormal_autophagy | 0.64489749 |
| 125 | MP0003279_aneurysm | 0.62162931 |
| 126 | MP0003806_abnormal_nucleotide_metabolis | 0.62123627 |
| 127 | MP0003045_fibrosis | 0.61815906 |
| 128 | MP0005076_abnormal_cell_differentiation | 0.61078670 |
| 129 | MP0005164_abnormal_response_to | 0.60254088 |
| 130 | MP0002084_abnormal_developmental_patter | 0.59298433 |
| 131 | MP0004185_abnormal_adipocyte_glucose | 0.57010661 |
| 132 | MP0001849_ear_inflammation | 0.54459906 |
| 133 | MP0003091_abnormal_cell_migration | 0.51900151 |
| 134 | MP0005621_abnormal_cell_physiology | 0.51179064 |
| 135 | MP0000609_abnormal_liver_physiology | 0.50191619 |
| 136 | MP0000604_amyloidosis | 0.47169728 |
| 137 | MP0004130_abnormal_muscle_cell | 0.46194230 |
| 138 | MP0005381_digestive/alimentary_phenotyp | 0.45529009 |
| 139 | MP0003453_abnormal_keratinocyte_physiol | 0.45228127 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 5.87460539 |
| 2 | Abnormality of cells of the erythroid lineage (HP:0012130) | 4.70760830 |
| 3 | Abnormality of macrophages (HP:0004311) | 4.56990003 |
| 4 | Recurrent bacterial skin infections (HP:0005406) | 4.55054602 |
| 5 | Abnormal number of erythroid precursors (HP:0012131) | 4.54067346 |
| 6 | Myositis (HP:0100614) | 4.35799209 |
| 7 | Stomatitis (HP:0010280) | 4.14881479 |
| 8 | Reticulocytopenia (HP:0001896) | 3.96212448 |
| 9 | Cellulitis (HP:0100658) | 3.76382590 |
| 10 | Increased IgE level (HP:0003212) | 3.66829983 |
| 11 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 3.59639140 |
| 12 | Orchitis (HP:0100796) | 3.56812511 |
| 13 | IgM deficiency (HP:0002850) | 3.53268291 |
| 14 | Agammaglobulinemia (HP:0004432) | 3.49050054 |
| 15 | Gastrointestinal infarctions (HP:0005244) | 3.42035886 |
| 16 | Purpura (HP:0000979) | 3.36617697 |
| 17 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.33955339 |
| 18 | Encephalitis (HP:0002383) | 3.33284722 |
| 19 | Panhypogammaglobulinemia (HP:0003139) | 3.28578051 |
| 20 | Abnormal platelet volume (HP:0011876) | 3.27574683 |
| 21 | Optic neuritis (HP:0100653) | 3.22320586 |
| 22 | Retrobulbar optic neuritis (HP:0100654) | 3.22320586 |
| 23 | Abnormality of B cell number (HP:0010975) | 3.18308566 |
| 24 | B lymphocytopenia (HP:0010976) | 3.18308566 |
| 25 | Meningitis (HP:0001287) | 3.06956612 |
| 26 | Recurrent skin infections (HP:0001581) | 3.04319565 |
| 27 | Combined immunodeficiency (HP:0005387) | 3.02031951 |
| 28 | Papilloma (HP:0012740) | 3.00882731 |
| 29 | Verrucae (HP:0200043) | 3.00882731 |
| 30 | T lymphocytopenia (HP:0005403) | 3.00293844 |
| 31 | Petechiae (HP:0000967) | 2.97811894 |
| 32 | Severe combined immunodeficiency (HP:0004430) | 2.96949316 |
| 33 | Increased IgM level (HP:0003496) | 2.96357567 |
| 34 | Vasculitis (HP:0002633) | 2.96214289 |
| 35 | Gingival bleeding (HP:0000225) | 2.96097287 |
| 36 | Thyroiditis (HP:0100646) | 2.90635649 |
| 37 | Pallor (HP:0000980) | 2.87865168 |
| 38 | Recurrent bronchitis (HP:0002837) | 2.84622227 |
| 39 | Macrocytic anemia (HP:0001972) | 2.84224468 |
| 40 | Autoimmune hemolytic anemia (HP:0001890) | 2.83517510 |
| 41 | Recurrent viral infections (HP:0004429) | 2.81371205 |
| 42 | Microcytic anemia (HP:0001935) | 2.81281905 |
| 43 | Type I transferrin isoform profile (HP:0003642) | 2.80786381 |
| 44 | Abnormality of T cell number (HP:0011839) | 2.80248839 |
| 45 | Menorrhagia (HP:0000132) | 2.80230697 |
| 46 | Abnormality of T cells (HP:0002843) | 2.76600935 |
| 47 | Prolonged bleeding time (HP:0003010) | 2.76285198 |
| 48 | Urticaria (HP:0001025) | 2.74093723 |
| 49 | Chest pain (HP:0100749) | 2.69760204 |
| 50 | Gingivitis (HP:0000230) | 2.68088858 |
| 51 | Increased mean platelet volume (HP:0011877) | 2.66346489 |
| 52 | Spontaneous hematomas (HP:0007420) | 2.64172364 |
| 53 | Thrombocytosis (HP:0001894) | 2.57217545 |
| 54 | Recurrent fungal infections (HP:0002841) | 2.55703072 |
| 55 | Hepatosplenomegaly (HP:0001433) | 2.54765380 |
| 56 | Basal cell carcinoma (HP:0002671) | 2.53495718 |
| 57 | Episodic fever (HP:0001954) | 2.51503017 |
| 58 | Hypertensive crisis (HP:0100735) | 2.49475307 |
| 59 | Hypergammaglobulinemia (HP:0010702) | 2.47118547 |
| 60 | Reduced antithrombin III activity (HP:0001976) | 2.46510712 |
| 61 | Keratoconjunctivitis sicca (HP:0001097) | 2.46106805 |
| 62 | Colitis (HP:0002583) | 2.45464783 |
| 63 | Lymphoma (HP:0002665) | 2.40283841 |
| 64 | Abnormality of the nasal mucosa (HP:0000433) | 2.40163376 |
| 65 | Increased serum ferritin (HP:0003281) | 2.39572285 |
| 66 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.38905577 |
| 67 | Hypochromic microcytic anemia (HP:0004840) | 2.35731430 |
| 68 | Pulmonary infiltrates (HP:0002113) | 2.32152666 |
| 69 | Birth length less than 3rd percentile (HP:0003561) | 2.31178022 |
| 70 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.30878864 |
| 71 | Absent thumb (HP:0009777) | 2.29973937 |
| 72 | Abnormality of reticulocytes (HP:0004312) | 2.29733595 |
| 73 | Abnormality of T cell physiology (HP:0011840) | 2.28979291 |
| 74 | Aplastic anemia (HP:0001915) | 2.26852385 |
| 75 | Arterial thrombosis (HP:0004420) | 2.26591484 |
| 76 | Keratoconjunctivitis (HP:0001096) | 2.21755711 |
| 77 | Selective tooth agenesis (HP:0001592) | 2.20202794 |
| 78 | Fatigue (HP:0012378) | 2.19635035 |
| 79 | Patellar aplasia (HP:0006443) | 2.15603539 |
| 80 | Muscle fiber atrophy (HP:0100295) | 2.15428939 |
| 81 | Abnormality of iron homeostasis (HP:0011031) | 2.15428384 |
| 82 | Hemoptysis (HP:0002105) | 2.14675060 |
| 83 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.14511532 |
| 84 | Chronic otitis media (HP:0000389) | 2.14403148 |
| 85 | Amaurosis fugax (HP:0100576) | 2.12603231 |
| 86 | Hypoplasia of the thymus (HP:0000778) | 2.12354077 |
| 87 | Skin ulcer (HP:0200042) | 2.11979096 |
| 88 | Breast hypoplasia (HP:0003187) | 2.09664451 |
| 89 | Epistaxis (HP:0000421) | 2.07131072 |
| 90 | Autoimmune thrombocytopenia (HP:0001973) | 2.07077041 |
| 91 | Recurrent abscess formation (HP:0002722) | 2.06899850 |
| 92 | Acute hepatic failure (HP:0006554) | 2.06387121 |
| 93 | Anorexia (HP:0002039) | 2.05963274 |
| 94 | Aplasia/Hypoplasia of the patella (HP:0006498) | 2.04594339 |
| 95 | Gastrointestinal inflammation (HP:0004386) | 2.04471975 |
| 96 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 2.04163336 |
| 97 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.03736545 |
| 98 | IgG deficiency (HP:0004315) | 2.02765592 |
| 99 | Granulocytopenia (HP:0001913) | 2.01713075 |
| 100 | Nasal polyposis (HP:0100582) | 2.00922154 |
| 101 | Myelodysplasia (HP:0002863) | 2.00388939 |
| 102 | Gastrointestinal stroma tumor (HP:0100723) | 1.99371842 |
| 103 | Abnormal platelet function (HP:0011869) | 1.98197551 |
| 104 | Impaired platelet aggregation (HP:0003540) | 1.98197551 |
| 105 | Microretrognathia (HP:0000308) | 1.96933466 |
| 106 | Pulmonary embolism (HP:0002204) | 1.96799461 |
| 107 | Trismus (HP:0000211) | 1.96667852 |
| 108 | Joint swelling (HP:0001386) | 1.96476491 |
| 109 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.96428319 |
| 110 | Chronic obstructive pulmonary disease (HP:0006510) | 1.95875121 |
| 111 | Obstructive lung disease (HP:0006536) | 1.95875121 |
| 112 | Meckel diverticulum (HP:0002245) | 1.95529686 |
| 113 | Abnormality of the ileum (HP:0001549) | 1.94303444 |
| 114 | Eosinophilia (HP:0001880) | 1.93732161 |
| 115 | Hypochromic anemia (HP:0001931) | 1.93430601 |
| 116 | Slow saccadic eye movements (HP:0000514) | 1.91797122 |
| 117 | Progressive muscle weakness (HP:0003323) | 1.89975954 |
| 118 | Lymphopenia (HP:0001888) | 1.89883118 |
| 119 | Hypertriglyceridemia (HP:0002155) | 1.89472383 |
| 120 | Increased density of long bones (HP:0006392) | 1.88041238 |
| 121 | Hypoproteinemia (HP:0003075) | 1.87804743 |
| 122 | Abnormal protein glycosylation (HP:0012346) | 1.86631074 |
| 123 | Abnormal glycosylation (HP:0012345) | 1.86631074 |
| 124 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.86631074 |
| 125 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.86631074 |
| 126 | Abnormality of the fingertips (HP:0001211) | 1.85369477 |
| 127 | Polycythemia (HP:0001901) | 1.84891542 |
| 128 | Skin rash (HP:0000988) | 1.82800128 |
| 129 | Inflammation of the large intestine (HP:0002037) | 1.81261178 |
| 130 | Recurrent cutaneous fungal infections (HP:0011370) | 1.80859104 |
| 131 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.80859104 |
| 132 | High pitched voice (HP:0001620) | 1.80630889 |
| 133 | Abnormality of eosinophils (HP:0001879) | 1.79614626 |
| 134 | Mediastinal lymphadenopathy (HP:0100721) | 1.78701666 |
| 135 | Leukocytosis (HP:0001974) | 1.78637524 |
| 136 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 1.78619414 |
| 137 | Sepsis (HP:0100806) | 1.78036979 |
| 138 | Bone marrow hypocellularity (HP:0005528) | 1.77489087 |
| 139 | Type 2 muscle fiber atrophy (HP:0003554) | 1.76563868 |
| 140 | Hypercortisolism (HP:0001578) | 1.76120275 |
| 141 | Neoplasm of the pancreas (HP:0002894) | 1.74049612 |
| 142 | Pustule (HP:0200039) | 1.73747228 |
| 143 | Osteomyelitis (HP:0002754) | 1.72101863 |
| 144 | Acute lymphatic leukemia (HP:0006721) | 1.71374880 |
| 145 | Poikilocytosis (HP:0004447) | 1.70361902 |
| 146 | 11 pairs of ribs (HP:0000878) | 1.69164739 |
| 147 | Multiple enchondromatosis (HP:0005701) | 1.68564391 |
| 148 | Abnormal number of incisors (HP:0011064) | 1.67317471 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 4.54749216 |
| 2 | MAP3K10 | 3.62033641 |
| 3 | NME2 | 3.55895316 |
| 4 | PRPF4B | 3.19511415 |
| 5 | EEF2K | 3.17930447 |
| 6 | MAP4K1 | 2.90106280 |
| 7 | BUB1 | 2.66961097 |
| 8 | WEE1 | 2.52392341 |
| 9 | TLK1 | 2.45408064 |
| 10 | KDR | 2.39452071 |
| 11 | PKN2 | 2.30206628 |
| 12 | TESK2 | 2.18872751 |
| 13 | NEK2 | 2.14645489 |
| 14 | STK10 | 2.11594190 |
| 15 | CDC7 | 2.09190117 |
| 16 | PASK | 1.89374990 |
| 17 | TRIB3 | 1.87756226 |
| 18 | BTK | 1.82450348 |
| 19 | TAOK3 | 1.72534413 |
| 20 | BLK | 1.71591714 |
| 21 | GRK6 | 1.69397024 |
| 22 | RPS6KB2 | 1.68698743 |
| 23 | MKNK2 | 1.65496581 |
| 24 | CLK1 | 1.62465918 |
| 25 | ERN1 | 1.60025264 |
| 26 | ZAP70 | 1.59966946 |
| 27 | MAP3K13 | 1.58344173 |
| 28 | MAP3K3 | 1.51818348 |
| 29 | SMG1 | 1.49510643 |
| 30 | CDK4 | 1.48150944 |
| 31 | FLT3 | 1.46589749 |
| 32 | RPS6KA4 | 1.45335406 |
| 33 | MAP3K14 | 1.44581720 |
| 34 | LRRK2 | 1.43816838 |
| 35 | TEC | 1.41863683 |
| 36 | PIM2 | 1.39014547 |
| 37 | NLK | 1.38822620 |
| 38 | DYRK3 | 1.38295721 |
| 39 | EPHB1 | 1.36526118 |
| 40 | SIK3 | 1.34444648 |
| 41 | TAOK2 | 1.34245971 |
| 42 | CDK7 | 1.33086630 |
| 43 | STK4 | 1.26278628 |
| 44 | MAPKAPK3 | 1.26191759 |
| 45 | PIM1 | 1.25938531 |
| 46 | MKNK1 | 1.25400966 |
| 47 | EIF2AK1 | 1.24543014 |
| 48 | JAK1 | 1.18994713 |
| 49 | MAP3K8 | 1.17579746 |
| 50 | TAOK1 | 1.14992496 |
| 51 | MAP3K11 | 1.14468925 |
| 52 | SRPK1 | 1.13403288 |
| 53 | MAP3K1 | 1.13266136 |
| 54 | JAK2 | 1.11245277 |
| 55 | TGFBR1 | 1.07736521 |
| 56 | BMPR2 | 1.07284740 |
| 57 | AURKB | 1.05423722 |
| 58 | IRAK4 | 1.04737486 |
| 59 | KSR2 | 1.02491807 |
| 60 | EIF2AK3 | 1.01132669 |
| 61 | PAK4 | 1.00889189 |
| 62 | MARK3 | 0.98477414 |
| 63 | SYK | 0.98236044 |
| 64 | SIK2 | 0.96447176 |
| 65 | VRK1 | 0.95504521 |
| 66 | PDK1 | 0.92071482 |
| 67 | SIK1 | 0.89333003 |
| 68 | CSK | 0.88533965 |
| 69 | FES | 0.87364300 |
| 70 | MAP2K3 | 0.86650246 |
| 71 | PLK1 | 0.86586776 |
| 72 | JAK3 | 0.86528977 |
| 73 | TTK | 0.84677927 |
| 74 | FGR | 0.84500807 |
| 75 | BMX | 0.83221206 |
| 76 | MARK2 | 0.81710617 |
| 77 | TESK1 | 0.80292165 |
| 78 | TGFBR2 | 0.78721961 |
| 79 | CDK12 | 0.77378220 |
| 80 | TIE1 | 0.77274537 |
| 81 | PDPK1 | 0.76890374 |
| 82 | ATR | 0.76462738 |
| 83 | FGFR4 | 0.75840289 |
| 84 | TXK | 0.75395100 |
| 85 | LCK | 0.74811502 |
| 86 | TYK2 | 0.71951465 |
| 87 | AURKA | 0.70959319 |
| 88 | PTK6 | 0.70503206 |
| 89 | LYN | 0.70235945 |
| 90 | MAPK4 | 0.70173786 |
| 91 | CSF1R | 0.69826452 |
| 92 | IRAK3 | 0.69702547 |
| 93 | ITK | 0.69475009 |
| 94 | ACVR1B | 0.69130362 |
| 95 | STK16 | 0.68386193 |
| 96 | BRSK2 | 0.63883691 |
| 97 | PRKD2 | 0.62087352 |
| 98 | PRKCQ | 0.61492757 |
| 99 | HCK | 0.59355309 |
| 100 | CAMKK1 | 0.58514334 |
| 101 | CDK6 | 0.58289627 |
| 102 | RAF1 | 0.57551496 |
| 103 | MAP3K6 | 0.56460395 |
| 104 | SCYL2 | 0.56244039 |
| 105 | ARAF | 0.55648875 |
| 106 | CHEK2 | 0.54994343 |
| 107 | FYN | 0.54938550 |
| 108 | BCKDK | 0.54864262 |
| 109 | IKBKE | 0.54351398 |
| 110 | MAP3K7 | 0.53830754 |
| 111 | PAK1 | 0.51873497 |
| 112 | MAPKAPK2 | 0.50695822 |
| 113 | MST4 | 0.50180581 |
| 114 | ILK | 0.49764312 |
| 115 | PIK3CG | 0.49730384 |
| 116 | HIPK2 | 0.49697432 |
| 117 | TBK1 | 0.48867186 |
| 118 | RPS6KC1 | 0.48220717 |
| 119 | RPS6KL1 | 0.48220717 |
| 120 | RPS6KA6 | 0.47863165 |
| 121 | PRKG2 | 0.47612541 |
| 122 | MAP2K2 | 0.47344184 |
| 123 | CDC42BPA | 0.46993952 |
| 124 | BRSK1 | 0.46359458 |
| 125 | KIT | 0.46182097 |
| 126 | RET | 0.45740732 |
| 127 | CAMKK2 | 0.45720311 |
| 128 | IRAK2 | 0.44379275 |
| 129 | ICK | 0.43780406 |
| 130 | IKBKB | 0.43386239 |
| 131 | PTK2B | 0.42908383 |
| 132 | CHEK1 | 0.42177698 |
| 133 | YES1 | 0.41938125 |
| 134 | MOS | 0.41906603 |
| 135 | PLK4 | 0.41795977 |
| 136 | TNK2 | 0.40378003 |
| 137 | IRAK1 | 0.39644420 |
| 138 | MAPK7 | 0.39348587 |
| 139 | NEK1 | 0.37548689 |
| 140 | MATK | 0.37420357 |
| 141 | CDK9 | 0.36574944 |
| 142 | CSNK2A2 | 0.36467854 |
| 143 | DYRK1B | 0.36285353 |
| 144 | CDK8 | 0.36091895 |
| 145 | RPS6KA5 | 0.36085463 |
| 146 | CDK2 | 0.35416591 |
| 147 | CSNK2A1 | 0.34950752 |
| 148 | FGFR3 | 0.34485535 |
| 149 | MAP3K5 | 0.33570062 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA replication_Homo sapiens_hsa03030 | 4.92797409 |
| 2 | Ribosome_Homo sapiens_hsa03010 | 4.01042137 |
| 3 | Mismatch repair_Homo sapiens_hsa03430 | 3.84437680 |
| 4 | Base excision repair_Homo sapiens_hsa03410 | 3.12393781 |
| 5 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.96644511 |
| 6 | Spliceosome_Homo sapiens_hsa03040 | 2.79897961 |
| 7 | Homologous recombination_Homo sapiens_hsa03440 | 2.73175652 |
| 8 | Allograft rejection_Homo sapiens_hsa05330 | 2.44207732 |
| 9 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.42477633 |
| 10 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.33618518 |
| 11 | * Cell cycle_Homo sapiens_hsa04110 | 2.22910555 |
| 12 | Proteasome_Homo sapiens_hsa03050 | 2.07218427 |
| 13 | One carbon pool by folate_Homo sapiens_hsa00670 | 2.00964535 |
| 14 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.99583579 |
| 15 | RNA transport_Homo sapiens_hsa03013 | 1.95866573 |
| 16 | RNA polymerase_Homo sapiens_hsa03020 | 1.86940653 |
| 17 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.86013714 |
| 18 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.78837089 |
| 19 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.78788629 |
| 20 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.69910347 |
| 21 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.68594162 |
| 22 | Tuberculosis_Homo sapiens_hsa05152 | 1.67204809 |
| 23 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.65247250 |
| 24 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.61304189 |
| 25 | * p53 signaling pathway_Homo sapiens_hsa04115 | 1.57931043 |
| 26 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.48772441 |
| 27 | Asthma_Homo sapiens_hsa05310 | 1.46588870 |
| 28 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.22273391 |
| 29 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.22229151 |
| 30 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.21856183 |
| 31 | Sulfur relay system_Homo sapiens_hsa04122 | 1.20256856 |
| 32 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.15139960 |
| 33 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.14883066 |
| 34 | RNA degradation_Homo sapiens_hsa03018 | 1.14479424 |
| 35 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.12572411 |
| 36 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.12107593 |
| 37 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.11476357 |
| 38 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.11103291 |
| 39 | Basal transcription factors_Homo sapiens_hsa03022 | 1.09826741 |
| 40 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.09480684 |
| 41 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.08183456 |
| 42 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.07962017 |
| 43 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.06466174 |
| 44 | Thyroid cancer_Homo sapiens_hsa05216 | 1.02796462 |
| 45 | * Measles_Homo sapiens_hsa05162 | 1.02185242 |
| 46 | Purine metabolism_Homo sapiens_hsa00230 | 1.01897942 |
| 47 | Phagosome_Homo sapiens_hsa04145 | 1.01328726 |
| 48 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.01076290 |
| 49 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.00964182 |
| 50 | * HTLV-I infection_Homo sapiens_hsa05166 | 1.00846348 |
| 51 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.98182950 |
| 52 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.96958772 |
| 53 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.96452930 |
| 54 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.96332783 |
| 55 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.96130106 |
| 56 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.95895115 |
| 57 | Leishmaniasis_Homo sapiens_hsa05140 | 0.94365606 |
| 58 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.93496097 |
| 59 | * Viral carcinogenesis_Homo sapiens_hsa05203 | 0.91370813 |
| 60 | Hepatitis C_Homo sapiens_hsa05160 | 0.91192235 |
| 61 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.91086248 |
| 62 | Endocytosis_Homo sapiens_hsa04144 | 0.89580789 |
| 63 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.87497522 |
| 64 | Salmonella infection_Homo sapiens_hsa05132 | 0.87251033 |
| 65 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.85316976 |
| 66 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.85235707 |
| 67 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.84446854 |
| 68 | Hepatitis B_Homo sapiens_hsa05161 | 0.83748934 |
| 69 | Apoptosis_Homo sapiens_hsa04210 | 0.82841965 |
| 70 | Shigellosis_Homo sapiens_hsa05131 | 0.82839271 |
| 71 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.77822677 |
| 72 | Pertussis_Homo sapiens_hsa05133 | 0.77498069 |
| 73 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.76711462 |
| 74 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.76394022 |
| 75 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.75363020 |
| 76 | Bladder cancer_Homo sapiens_hsa05219 | 0.74378139 |
| 77 | Endometrial cancer_Homo sapiens_hsa05213 | 0.74108050 |
| 78 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.73031050 |
| 79 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.72358868 |
| 80 | Other glycan degradation_Homo sapiens_hsa00511 | 0.72084908 |
| 81 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.71672182 |
| 82 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.71627247 |
| 83 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.71586950 |
| 84 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.71440241 |
| 85 | Colorectal cancer_Homo sapiens_hsa05210 | 0.70798811 |
| 86 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.69731847 |
| 87 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.67537179 |
| 88 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.66451475 |
| 89 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.65521194 |
| 90 | * Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.63271221 |
| 91 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.62430722 |
| 92 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.62229996 |
| 93 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.60846506 |
| 94 | Platelet activation_Homo sapiens_hsa04611 | 0.60728989 |
| 95 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.60147655 |
| 96 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.59504144 |
| 97 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.57574765 |
| 98 | Viral myocarditis_Homo sapiens_hsa05416 | 0.57353792 |
| 99 | Lysosome_Homo sapiens_hsa04142 | 0.55524283 |
| 100 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.55380605 |
| 101 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.53458887 |
| 102 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.53346238 |
| 103 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.53176324 |
| 104 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.53044606 |
| 105 | Glioma_Homo sapiens_hsa05214 | 0.52808553 |
| 106 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.51253140 |
| 107 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.50313649 |
| 108 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.50123257 |
| 109 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.49063570 |
| 110 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.48975152 |
| 111 | Pathways in cancer_Homo sapiens_hsa05200 | 0.47698541 |
| 112 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.47467556 |
| 113 | Malaria_Homo sapiens_hsa05144 | 0.47180555 |
| 114 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.46725543 |
| 115 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.46260527 |
| 116 | Prostate cancer_Homo sapiens_hsa05215 | 0.45798767 |
| 117 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.45308893 |
| 118 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.45021901 |
| 119 | Legionellosis_Homo sapiens_hsa05134 | 0.45000591 |
| 120 | Protein export_Homo sapiens_hsa03060 | 0.42058503 |
| 121 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.41416979 |
| 122 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.41034477 |
| 123 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.40600238 |
| 124 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.38750618 |
| 125 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.38692238 |
| 126 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.38352858 |
| 127 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.37439557 |
| 128 | Amoebiasis_Homo sapiens_hsa05146 | 0.36703922 |
| 129 | Insulin resistance_Homo sapiens_hsa04931 | 0.35412398 |
| 130 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.35012596 |
| 131 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.34898193 |
| 132 | Influenza A_Homo sapiens_hsa05164 | 0.34163983 |
| 133 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.34157517 |
| 134 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.32124497 |
| 135 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.31786743 |
| 136 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.27505596 |
| 137 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.26116840 |
| 138 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.25974371 |
| 139 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.23712783 |
| 140 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.23680090 |
| 141 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.23182994 |
| 142 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.22795022 |
| 143 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.22636619 |
| 144 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.22150955 |
| 145 | Alcoholism_Homo sapiens_hsa05034 | 0.21592987 |

